Related Experiment Video
Updated: May 4, 2026

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
The "coagulation box" and a new hemoglobin-driven algorithm for bleeding control in patients with severe multiple
Peter Hilbert1, Gunther Olaf Hofmann2, Jörg Teichmann3
1Department of Anesthesiology, Intensive Care and Emergency Medicine, BG-Kliniken Bergmannstrost, Halle, Germany.
An Hb-driven algorithm guides early clotting therapy in trauma patients, improving outcomes. This approach utilizes readily available hemoglobin levels to initiate treatment, potentially reducing mortality from hemorrhage.
Area of Science:
- Trauma Care
- Hemorrhage Management
- Coagulation Disorders
Background:
- Extensive hemorrhage is a leading cause of early death in multiple trauma patients.
- Timely intervention for clotting disorders is crucial for reducing mortality.
- Hemoglobin (Hb) levels offer a rapid assessment compared to delayed coagulation studies.
Purpose of the Study:
- To evaluate an Hb-driven algorithm for guiding initial clotting therapy in multiple trauma patients.
- To assess the efficacy of early intervention using specific clotting factors and blood products.
Main Methods:
- Development of a three-step Hb-driven algorithm for aggressive clotting therapy.
- Utilization of a "coagulation box" for immediate access to fibrinogen, PCC, factor VIIa, tranexamic acid, and desmopressin.
- Transfusion strategy with an RBC-to-FFP ratio of 2:1 to 1:1.
Main Results:
- 123 severe trauma patients were included; 25 were treated with the "coagulation box" algorithm.
- Patients receiving the algorithm treatment showed marked improvement in clotting parameters.
- Survival rate for the algorithm group was 64%, exceeding the predicted survival rate (41%).
Conclusions:
- An Hb-driven algorithm combined with early clotting factor administration is a simple and effective strategy.
- The "coagulation box" facilitates rapid treatment initiation for coagulopathy in trauma.
- This approach shows potential for improving survival rates in multiple trauma patients.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins

